3004.49.00.30 - Antidepressants, tranquilizers and other psychotherapeutic agents 🖩

This HTS subcategory, 3004.49.00.30, specifically classifies antidepressants, tranquilizers, and other psychotherapeutic agents. These are medicinal preparations, whether mixed or unmixed, that are intended for therapeutic or prophylactic use and are presented in measured doses or in forms suitable for retail sale. The core characteristic of items in this category is their primary intended pharmacological action on the central nervous system to address conditions related to mood, anxiety, psychosis, and other mental or emotional disorders.

This classification is distinct from its sibling category, 3004.49.00.20, which pertains to anticonvulsants, hypnotics, and sedatives. While all these classes of drugs affect the central nervous system, the distinction lies in their primary therapeutic purpose. Anticonvulsants are for seizure control, hypnotics induce sleep, and sedatives reduce nervous excitement. In contrast, 3004.49.00.30 is reserved for agents directly targeting mood regulation, anxiety reduction, and the management of more complex psychotherapeutic conditions. The sibling 3004.49.00.40, designated as "Other," serves as a residual category for central nervous system-acting drugs that do not fall into the more specific subclasses.

As this is a leaf node within the HTS, there are no further subdivisions. Therefore, the classification of a product under 3004.49.00.30 hinges directly on its confirmed psychotherapeutic function and its presentation for therapeutic or prophylactic use in measured doses or retail packaging. Examples of products classified here would include specific selective serotonin reuptake inhibitors (SSRIs), benzodiazepines prescribed for anxiety disorders, antipsychotic medications, and mood stabilizers.